Richard A. Franklin

12.5k total citations · 6 hit papers
146 papers, 9.5k citations indexed

About

Richard A. Franklin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Richard A. Franklin has authored 146 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 43 papers in Oncology and 18 papers in Immunology. Recurrent topics in Richard A. Franklin's work include Cytokine Signaling Pathways and Interactions (21 papers), Protein Kinase Regulation and GTPase Signaling (21 papers) and PI3K/AKT/mTOR signaling in cancer (16 papers). Richard A. Franklin is often cited by papers focused on Cytokine Signaling Pathways and Interactions (21 papers), Protein Kinase Regulation and GTPase Signaling (21 papers) and PI3K/AKT/mTOR signaling in cancer (16 papers). Richard A. Franklin collaborates with scholars based in United States, United Kingdom and Italy. Richard A. Franklin's co-authors include James A. McCubrey, Linda S. Steelman, William L. Blalock, Michelle M. LaHair, J G Shelton, Patrick M. Navolanic, Fuju Chang, Fumin Chang, Massimo Libra and Franca Stivala and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Richard A. Franklin

145 papers receiving 9.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

2006 1.9k citations James A. McCubrey, Linda S. Steelman et al. profile →
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy

2003 999 citations Patrick M. Navolanic, Linda S. Steelman et al. Leukemia profile →
Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways

2006 672 citations James A. McCubrey, Michelle M. LaHair et al. profile →
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention

2003 577 citations Linda S. Steelman, J G Shelton et al. Leukemia profile →
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis

2004 555 citations Linda S. Steelman, J G Shelton et al. Leukemia profile →
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

2006 550 citations James A. McCubrey, Linda S. Steelman et al. Advances in Enzyme Regulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard A. Franklin United States	41	5.8k	2.4k	1.3k	1.2k	853	146	9.5k
Patrick Auberger France	52	6.5k 1.1×	2.1k 0.9×	2.1k 1.6×	1.9k 1.5×	494 0.6×	193	10.5k
Linda S. Steelman United States	49	7.5k 1.3×	3.3k 1.4×	1.9k 1.5×	990 0.8×	1.2k 1.4×	112	11.2k
Curt Milliman United States	9	9.6k 1.6×	2.8k 1.2×	1.5k 1.2×	2.4k 1.9×	1.2k 1.4×	9	14.1k
Kenneth V. Honn United States	63	5.0k 0.9×	2.9k 1.2×	3.4k 2.7×	1.1k 0.9×	499 0.6×	243	12.8k
Kazuo Umezawa Japan	51	5.3k 0.9×	2.1k 0.9×	2.4k 1.9×	2.1k 1.7×	702 0.8×	425	11.0k
Alexandru Almasan United States	45	4.4k 0.8×	1.9k 0.8×	1.0k 0.8×	951 0.8×	502 0.6×	96	6.5k
Henning R. Stennicke Denmark	29	6.6k 1.1×	1.5k 0.6×	938 0.7×	1.5k 1.2×	477 0.6×	56	8.9k
Mayumi Ono Japan	61	7.4k 1.3×	4.0k 1.7×	2.2k 1.7×	1.7k 1.4×	823 1.0×	214	12.1k
David T. Dudley United States	24	5.6k 1.0×	1.6k 0.7×	944 0.8×	1.1k 0.9×	535 0.6×	39	8.6k
Nika N. Danial United States	35	7.2k 1.2×	1.5k 0.6×	1.2k 1.0×	1.5k 1.3×	702 0.8×	56	10.4k

Countries citing papers authored by Richard A. Franklin

Since Specialization

Citations

This map shows the geographic impact of Richard A. Franklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Franklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Franklin more than expected).

Fields of papers citing papers by Richard A. Franklin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard A. Franklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Franklin. The network helps show where Richard A. Franklin may publish in the future.

Co-authorship network of co-authors of Richard A. Franklin

This figure shows the co-authorship network connecting the top 25 collaborators of Richard A. Franklin. A scholar is included among the top collaborators of Richard A. Franklin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A. Franklin. Richard A. Franklin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ciuffreda, Ludovica, Ursula Cesta Incani, Linda S. Steelman, et al.. (2014). Signaling Intermediates (MAPK and PI3K) as Therapeutic Targets in NSCLC. Current Pharmaceutical Design. 20(24). 3944–3957. 52 indexed citations

Steelman, Linda S., Patrick M. Navolanic, William H. Chappell, et al.. (2011). Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells. Cell Cycle. 10(17). 3003–3015. 70 indexed citations

McCubrey, James A., William H. Chappell, Stephen L. Abrams, et al.. (2010). Targeting the cancer initiating cell: The Achilles’ heel of cancer. Advances in Enzyme Regulation. 51(1). 152–162. 9 indexed citations

García-Sánchez, José Rubén, Richard A. Franklin, & James A. McCubrey. (2006). EGF Induces Cell Motility and Multi-Drug Resistance Gene Expression in Breast Cancer Cells. Cell Cycle. 5(23). 2820–2826. 60 indexed citations

McCubrey, James A., John G. Shelton, Linda S. Steelman, et al.. (2004). Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells. Oncogene. 23(47). 7810–7820. 12 indexed citations

Howe, Christopher J., et al.. (2003). Models of Anergy in the Human Jurkat T Cell Line. Assay and Drug Development Technologies. 1(4). 537–544. 11 indexed citations

Franklin, Richard A.. (2003). Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro. Obstetrics and Gynecology. 101(3). 455–462. 52 indexed citations

Blalock, William L., Patrick M. Navolanic, Linda S. Steelman, et al.. (2003). Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia. Leukemia. 17(6). 1058–1067. 50 indexed citations

Martin, Elizabeth A., et al.. (2000). Oxidative Stress Regulates the Interaction of p16 with Cdk4. Biochemical and Biophysical Research Communications. 275(3). 764–767. 10 indexed citations

10.

Melamed, Isaac, Richard A. Franklin, & Erwin W. Gelfand. (1995). Microfilament Assembly Is Required for Anti-IgM Dependent Mapk and p90rsk Activation in Human B Lymphocytes. Biochemical and Biophysical Research Communications. 209(3). 1102–1110. 11 indexed citations

11.

Franklin, Richard A., Attila Tordai, Bruce Mazer, et al.. (1994). Activation of MAP2-kinase in B lymphocytes by calcium ionophores.. The Journal of Immunology. 153(11). 4890–4898. 26 indexed citations

12.

Kavelaars, Annemieke, Frank J. Jeurissen, Alexander B. Meijer, et al.. (1994). Activation of human monocytes via a non-neurokinin substance P receptor that is coupled to Gi protein, calcium, phospholipase D, MAP kinase, and IL-6 production.. The Journal of Immunology. 153(8). 3691–3699. 69 indexed citations

13.

Sawami, H, et al.. (1991). B-cell activation and regulation of immunoglobulin synthesis by platelet activating factor.. PubMed. 39(3-4). 244–53. 7 indexed citations

14.

Franklin, Richard A., et al.. (1989). Interleukin-2 suppression in cats naturally infected with feline leukemia virus.. PubMed. 8(1). 86–96. 16 indexed citations

15.

Tompkins, Mary B., Gregory K. Ogilvie, Richard A. Franklin, Keith W. Kelley, & W. A. F. Tompkins. (1987). Induction of IL-2 and lymphokine activated killer cells in the cat. Veterinary Immunology and Immunopathology. 16(1-2). 1–10. 39 indexed citations

16.

Franklin, Richard A., et al.. (1987). Chicken Serum Inhibits Lectin-Induced Proliferation of Autologous Splenic Mononuclear Cells. Experimental Biology and Medicine. 184(2). 225–233. 9 indexed citations

17.

Fromson, J. M., et al.. (1981). The Drug Metabolism Discussion Group. Xenobiotica. 11(12). 801–801. 1 indexed citations

18.

Franklin, Richard A., et al.. (1977). The disposition of a novel pyrimidoindole, ciclazindol, in the rat and patas monkey.. Drug Metabolism and Disposition. 5(5). 419–424. 1 indexed citations

19.

Franklin, Richard A., et al.. (1976). On the relation between the analgesic activity of meptazinol and its plasma concentrations in rats, mice and monkeys. Journal of Pharmacy and Pharmacology. 28(11). 852–853. 5 indexed citations

20.

Sobotka, Anna, Richard A. Franklin, & Martin D. Valentine. (1974). Honeybee venom: phospholipase A as the major allergen. Journal of Allergy and Clinical Immunology. 53(2). 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact